Release Date: 27/06/18 17:47 Summary: Estimated Distribution Announcement Price Sensitive: Yes Download Document 103.79KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%